Christine Yoder

Introduction

Christine Yoder is an innovative inventor based in Salem, Connecticut, who has made significant contributions to the field of biotechnology. With one patent to her name, she focuses on advancements that have the potential to impact health and disease management.

Latest Patents

Yoder's patent addresses the development of polynucleotide molecules encoding Neospora proteins. This invention provides isolated polynucleotide molecules that comprise nucleotide sequences encoding GRA, SAG, MIC, and MAG proteins. Additionally, the invention encompasses recombinant vectors, transformed host cells, and recombinantly-expressed proteins. A notable feature of her patent is the polynucleotide molecule that contains the nucleotide sequence of the bidirectional GRA1IMAGI promoter. Moreover, the constructs derived from these polynucleotide molecules are aimed at creating modified strains of Neospora cells, with applications for vaccines against neosporosis.

Career Highlights

Yoder's career in the biotechnology sector highlights her commitment to research and innovation. Her focus on Neospora proteins signifies her role in combating diseases that affect livestock and can indirectly impact food security.

Collaborations

Christine collaborates with notable professionals, including B Rajendra Krishnan and Rebecca Madura, to further her research and development efforts. These collaborations enhance the robustness of her inventions and contribute to a well-rounded approach to her work.

Conclusion

Christine Yoder stands out as a dedicated inventor in the biotechnology field, with a focus on innovative solutions for health challenges. Her patent plays an important role in advancing our understanding of Neospora and could be foundational in developing effective vaccines. Through her collaborations and ongoing research, Yoder continues to contribute significantly to the realm of science and technology.